Quarterly report pursuant to Section 13 or 15(d)

CONDENSED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.23.1
CONDENSED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2021 $ 10,216 $ 38,948,334 $ (26,548,309) $ 12,410,241
Balance at beginning, Common shares (in shares) at Dec. 31, 2021 10,215,792      
Share-Based Compensation   761,069   761,069
Share-Based Payments to Vendors $ 44 188,056   188,100
Share-Based Payments to Vendors (in shares) 43,889      
Cashless Warrant Exercise $ 3 (3)    
Cashless Warrant Exercise (in shares) 3,521      
Net Loss     (2,670,138) (2,670,138)
Balance at ending at Mar. 31, 2022 $ 10,263 39,897,456 (29,218,447) 10,689,272
Balance at ending, Common shares (in shares) at Mar. 31, 2022 10,263,202      
Balance at beginning at Dec. 31, 2022 $ 11,628 45,944,478 (38,641,085) $ 7,315,021
Balance at beginning, Common shares (in shares) at Dec. 31, 2022 11,627,609     11,627,609
Share-Based Compensation   733,472   $ 733,472
Share-Based Payments to Vendors $ 44 165,859   165,903
Share-Based Payments to Vendors (in shares) 44,186      
Net Loss     (2,902,957) (2,902,957)
Balance at ending at Mar. 31, 2023 $ 11,672 $ 46,843,809 $ (41,544,042) $ 5,311,439
Balance at ending, Common shares (in shares) at Mar. 31, 2023 11,671,795     11,671,795